Wasat Mansoor
8PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.Wasat Mansoor, Seongjung Joo, Josephine M Norquist
|May 09, 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.Susanna Hegewisch-Becker, Guillermo Mendez, Joseph Chao
|Nov 03, 2021
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.Antoine Adenis, Amit S Kulkarni, Gustavo C Girotto
|May 26, 2021
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.Wasat Mansoor, Eric J Roeland, Aafia Chaudhry
|Mar 13, 2021
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.Wasat Mansoor, Hendrik-Tobias Arkenau, Maria Alsina
|Mar 20, 2020
Diagnostic and Management Pathways for Pulmonary Carcinoid Tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project.Wasat Mansoor, Stuart Ferguson, Victoria Ross
Pageof 2
Frequent Collaborators
1 joint publications
Marc Abraham
1 joint publications
Jorge Barriuso
1 joint publications
Jamie M J Weaver
1 joint publications
Antoine Adenis
1 joint publications
Gustavo C Girotto
1 joint publications
Christelle de la Fouchardiere
1 joint publications
Hanneke W M van Laarhoven
1 joint publications
Susanna Hegewisch-Becker
1 joint publications
Joseph Chao
1 joint publications
Eric Van Cutsem
